David  Linetsky net worth and biography

David Linetsky Biography and Net Worth

SVP of Phreesia
David Linetsky is responsible for cultivating Phreesia’s partnerships with Life Sciences companies, supporting them in the development of healthcare products that deliver value and engage patients in their care. He has worked at Phreesia for more than a decade and held key leadership roles, including Vice President of Analytics and Insights, and Vice President of Finance.

Prior to joining Phreesia, David worked in academia as a researcher and instructor in the fields of biotechnology, mathematics and philosophy. David holds a BS in mathematics from the University of Alberta. He also earned a master’s degree and was a PhD candidate in mathematics and logic at the City University of New York.

What is David Linetsky's net worth?

The estimated net worth of David Linetsky is at least $3.69 million as of October 18th, 2024. Mr. Linetsky owns 200,207 shares of Phreesia stock worth more than $3,693,819 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Linetsky may own. Additionally, Mr. Linetsky receives an annual salary of $551,640.00 as SVP at Phreesia. Learn More about David Linetsky's net worth.

How old is David Linetsky?

Mr. Linetsky is currently 44 years old. There are 6 older executives and no younger executives at Phreesia. Learn More on David Linetsky's age.

What is David Linetsky's salary?

As the SVP of Phreesia, Inc., Mr. Linetsky earns $551,640.00 per year. Learn More on David Linetsky's salary.

How do I contact David Linetsky?

The corporate mailing address for Mr. Linetsky and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on David Linetsky's contact information.

Has David Linetsky been buying or selling shares of Phreesia?

During the past quarter, David Linetsky has sold $64,830.33 of Phreesia stock. Most recently, David Linetsky sold 1,100 shares of the business's stock in a transaction on Friday, October 18th. The shares were sold at an average price of $20.49, for a transaction totalling $22,539.00. Following the completion of the sale, the senior vice president now directly owns 200,207 shares of the company's stock, valued at $4,102,241.43. Learn More on David Linetsky's trading history.

Who are Phreesia's active insiders?

Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.

Are insiders buying or selling shares of Phreesia?

In the last twelve months, insiders at the sold shares 56 times. They sold a total of 151,985 shares worth more than $3,552,098.43. The most recent insider tranaction occured on October, 18th when SVP David Linetsky sold 1,100 shares worth more than $22,539.00. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.

Information on this page was last updated on 10/18/2024.

David Linetsky Insider Trading History at Phreesia

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/18/2024Sell1,100$20.49$22,539.00200,207View SEC Filing Icon  
10/15/2024Sell2,011$21.03$42,291.33201,307View SEC Filing Icon  
9/19/2024Sell24$24.04$576.968,971View SEC Filing Icon  
9/17/2024Sell36$24.77$891.729,056View SEC Filing Icon  
9/10/2024Sell1,716$23.25$39,897.00203,318View SEC Filing Icon  
7/16/2024Sell1,820$23.74$43,206.80202,218View SEC Filing Icon  
6/20/2024Sell66$19.73$1,302.186,980View SEC Filing Icon  
6/18/2024Sell41$19.20$787.207,046View SEC Filing Icon  
4/18/2024Sell269$22.85$6,146.657,087View SEC Filing Icon  
3/18/2024Sell46$22.22$1,022.127,527View SEC Filing Icon  
12/18/2023Sell234$23.15$5,417.107,598View SEC Filing Icon  
9/18/2023Sell130$19.67$2,557.107,832View SEC Filing Icon  
2/2/2023Sell11,378$39.55$449,999.90205,489View SEC Filing Icon  
12/13/2022Sell11,377$34.61$393,757.97185,485View SEC Filing Icon  
12/9/2022Sell26,837$29.77$798,937.49196,862View SEC Filing Icon  
11/8/2021Sell1,499$75.12$112,604.88View SEC Filing Icon  
11/5/2021Sell3,478$75.15$261,371.70View SEC Filing Icon  
11/1/2021Sell5,451$70.88$386,366.88View SEC Filing Icon  
10/15/2021Sell5,452$65.36$356,342.72View SEC Filing Icon  
9/1/2021Sell4,978$70.42$350,550.76View SEC Filing Icon  
8/27/2021Sell21,455$71.85$1,541,541.75View SEC Filing Icon  
8/25/2021Sell500$70.04$35,020.00View SEC Filing Icon  
3/15/2021Sell48,482$61.15$2,964,674.30View SEC Filing Icon  
1/19/2021Sell5,136$64.28$330,142.08View SEC Filing Icon  
10/1/2020Sell4,477$30.97$138,652.69View SEC Filing Icon  
7/1/2020Sell4,475$28.24$126,374.00View SEC Filing Icon  
4/27/2020Sell4,220$26.00$109,720.00View SEC Filing Icon  
See Full Table

David Linetsky Buying and Selling Activity at Phreesia

This chart shows David Linetsky's buying and selling at Phreesia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Phreesia Company Overview

Phreesia logo
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Read More

Today's Range

Now: $18.45
Low: $18.19
High: $18.72

50 Day Range

MA: $20.98
Low: $18.04
High: $24.68

2 Week Range

Now: $18.45
Low: $14.55
High: $29.16

Volume

27,491 shs

Average Volume

448,904 shs

Market Capitalization

$1.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94